Re perceived discrepancy between PFS and OS time frames in Roth Report and Clinicaltrials.gov re Hervaxx, I received an email response from the same email address I used to contact the Roth Report writer. The response is as follows:
”You are talking about how long it takes each individual patient to progress or die, on average. I am talking about when enough patients experience that so that they can release the data. They are two very different things.”
I can’t say that I fully understand that, but in relation to the Phase 1 results and the “beautiful numbers”, it infers that not enough patients have progressed or died such that data can be released. Leslie did say something similar.
I just don’t understand how Roth can put a time estimate on it.
In any event, I am confident great things will be achieved well before then.
Go Imugene.
PDS
Roth just rated IMU a buy, page-66
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $431.8M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.6¢ | $1.037M | 17.94M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1882949 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 399643 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1874329 | 0.058 |
9 | 1728227 | 0.057 |
23 | 4466894 | 0.056 |
27 | 3648665 | 0.055 |
8 | 305000 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 1360 | 1 |
0.060 | 2622845 | 17 |
0.061 | 773907 | 4 |
0.062 | 2227969 | 6 |
0.063 | 243179 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online